Skip to content
Disclosery

EXANE DERIVATIVES: MRNA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on MRNA, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 4,267 MRNA shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 4,267 shares
    Change vs previous 13F +350 shares

    0.35% of the 13F portfolio, value $609,417.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 3,917 shares
    Change vs previous 13F -14 shares

    0.19% of the 13F portfolio, value $674,701.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,931 shares
    Change vs previous 13F +1,577 shares

    0.24% of the 13F portfolio, value $998,359.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,354 shares
    Change vs previous 13F -139 shares

    0.23% of the 13F portfolio, value $905,928.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,493 shares
    Change vs previous 13F -6,262 shares

    0.14% of the 13F portfolio, value $586,216.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 8,755 shares
    Change vs previous 13F +6,227 shares

    0.35% of the 13F portfolio, value $1,146,417.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,528 shares
    Change vs previous 13F +178 shares

    0.08% of the 13F portfolio, value $264,088.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 2,350 shares
    Change vs previous 13F not available

    0.05% of the 13F portfolio, value $166,253.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).